Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance

In idiopathic pulmonary arterial hypertension (PAH), increased pulmonary vascular resistance is associated with structural narrowing of small (resistance) vessels and increased vascular tone. Current information on pulmonary vascular remodeling is mostly limited to averaged increases in wall thickness, but information on number of vessels affected and internal diameter decreases for vessels of different sizes is limited. Our aim was to quantify numbers of affected vessels and their internal diameter decrease for differently sized vessels in PAH in comparison with non‐PAH patients. Internal and external diameters of transversally cut vessels were measured in five control subjects and six PAH patients. Resistance vessels were classified in Strahler orders, internal diameters 13 μm (order 1) to 500 μm (order 8). The number fraction, that is, percentage of affected vessels, and the internal diameter fraction, that is, percentage diameter of normal diameter, were calculated. In PAH, not all resistance vessels are affected. The number fraction is about 30%, that is, 70% of vessels have diameters not different from vessels of control subjects. Within each order, the decrease in diameter of affected vessels is variable with an averaged diameter fraction of 50–70%. Narrowing of resistance vessels is heterogeneous: not all vessels are narrowed, and the decrease in internal diameters, even within a single order, vary largely. This heterogeneous narrowing alone cannot explain the large resistance increase in PAH. We suggest that rarefaction could be an important contributor to the hemodynamic changes.

[1]  L. Reid,et al.  The radiographic appearances in primary and in thrombo-embolic pulmonary hypertension. , 1973, Clinical radiology.

[2]  B. Dijkmans,et al.  Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension , 2008, European Respiratory Journal.

[3]  K. S. Burrowes,et al.  Pulmonary embolism: predicting disease severity , 2011, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[4]  A. Peacock,et al.  Pulmonary circulation : diseases and their treatment , 2004 .

[5]  M. Humbert,et al.  Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature , 2014, European Respiratory Journal.

[6]  B. Dijkmans,et al.  Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy , 2009, European Respiratory Journal.

[7]  C. Mélot,et al.  Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. , 1998, Journal of the American College of Cardiology.

[8]  V. S. Zhdanov,et al.  Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. , 1995, The American journal of pathology.

[9]  Nico Westerhof,et al.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension. , 2006, American journal of physiology. Heart and circulatory physiology.

[10]  S. Groshong,et al.  Modern age pathology of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[11]  T. Hakim,et al.  Occlusion pressures vs. micropipette pressures in the pulmonary circulation. , 1989, Journal of applied physiology.

[12]  K. Horsfield,et al.  Morphometry of the Small Pulmonary Arteries in Man , 1978, Circulation research.

[13]  H. Palevsky,et al.  Classification of Histologic Lesions in Primary Pulmonary Hypertension Group Medial lesions Intimal lesions Medial hypertrophy Increased smooth muscle , 2005 .

[14]  R. Yen,et al.  Morphometry of the human pulmonary vasculature. , 1996, Journal of applied physiology.

[15]  W. Mooi,et al.  Decreased numbers of pulmonary blood vessels: Reality or artifact? , 1983, The Journal of pathology.

[16]  Nico Westerhof,et al.  Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. , 2008, European heart journal.